Stefan Erfurt,Meike Hoffmeister,Stefanie Oess et al.
Stefan Erfurt et al.
Introduction:: The prediction of acute kidney injury (AKI)-related outcomes remains challenging. Herein we prospectively quantified soluble ST2 (sST2), the circulating isoform of the IL-33 receptor, in hospitalized patien...
Assessment of background levels of autoantibodies as a prognostic marker for severe SARS-CoV-2 infection [0.03%]
自身抗体背景水平作为严重SARS-CoV-2感染预后标志物的评估
Frank M Sullivan,Agnes Tello,Petra Rauchhaus et al.
Frank M Sullivan et al.
Background:: Patients with more severe forms of SARS-CoV-2 exhibit activation of immunological cascades. Participants (current or ex-smokers with at least 20 years pack history) in a trial (Early Diagnosis of Lung Cancer,...
Hadi Sodagar,Shahriar Alipour,Sepideh Hassani et al.
Hadi Sodagar et al.
Objective:: Epigenetics is a quickly spreading scientific field, and the study of epigenetic regulation in various diseases such as infectious diseases is emerging. The microribonucleic acids (miRNAs) as one of the types ...
MicroRNAs from urinary exosomes as alternative biomarkers in the differentiation of benign and malignant prostate diseases [0.03%]
尿液外泌体中的microRNA作为区分良性及恶性前列腺疾病的替代性标志物研究
Jonas Holdmann,Lukas Markert,Claudia Klinger et al.
Jonas Holdmann et al.
Introduction:: Prostate cancer (PCa) is the second most frequently diagnosed cancer and the fifth most cancer-related cause of death worldwide. Various tools are used in the diagnosis of PCa, such as the Prostate-Specific...
Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease [0.03%]
慢性肾脏病患者FGF-23诊断作用及其对矿物质骨代谢的作用机制
Luisa Albanese,Gemma Caliendo,Giovanna DElia et al.
Luisa Albanese et al.
Our data confirm that intact fibroblast growth factor 23 (iFGF-23) concentration is increased in patients with chronic kidney disease (CKD) and that it increases with disease progression (stages I-V). Therefore, iFGF-23 could be considered ...
Pharmacokinetics of the disialoganglioside, GD2, a circulating tumor biomarker for neuroblastoma, in nonhuman primates [0.03%]
非人灵长类动物中二唾液酸神经节苷脂GD2的药代动力学研究(GD2是神经母细胞瘤的一种循环肿瘤标志物)
Frank M Balis,Cynthia Lester McCully,Christine M Busch et al.
Frank M Balis et al.
Background:: The ganglioside GD2 is a potential circulating tumor biomarker for the childhood cancer neuroblastoma. Interpreting the levels of a circulating tumor biomarker depends in part on a knowledge of the biomarker...
Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification? [0.03%]
作为不同疾病生物标志物的血清IL-33:有用参数还是需要澄清?
Stefan Erfurt,Meike Hoffmeister,Stefanie Oess et al.
Stefan Erfurt et al.
Interleukin-33 (IL-33), a member of the IL-1 family, is critically involved in the modulation of the activity of a diverse range of immunocompetent cells. Essential roles have been implicated in cardioprotection, in both innate and adaptive...
Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage [0.03%]
与全身性疾病有关的循环中幼红细胞异常可能是骨髓损伤的征象
Stefan Schreier,Prapaphan Budchart,Suparerk Borwornpinyo et al.
Stefan Schreier et al.
Background:: The circulating rare cell population is diverse and rich in diagnostic information. Its characterization and clinical exploitation by cell-based liquid biopsy is an ongoing research task. Bone marrow is one o...
Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring [0.03%]
循环前胃泌素释放肽在小细胞肺癌诊断和治疗监测中的作用
Vittoria Barchiesi,Vittorio Simeon,Claudia Sandomenico et al.
Vittoria Barchiesi et al.
Introduction:: Progastrin-releasing peptide (proGRP), a precursor of GRP, has been recently reported as a putative circulating biomarker for differential diagnosis between non–small cell lung cancer (NSCLC) and SCLC. We ...
Development of an immunofluorescent AR-V7 circulating tumor cell assay - A blood-based test for men with metastatic prostate cancer [0.03%]
一种AR-V7阳性循环肿瘤细胞免疫荧光检测试剂盒的开发及应用——前列腺癌患者血液检测的新方法
David Lu,Rachel Krupa,Melissa Harvey et al.
David Lu et al.
Introduction: Here we describe the development of a protein immunofluorescent assay for the detection of nuclear-localized androgen receptor variant 7 (AR-V7) protein within circulating tumor cells (CTCs) identified in pa...